| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |